434 related articles for article (PubMed ID: 30504320)
1. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
2. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
Kunimoto H; Nakajima H
Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
[TBL] [Abstract][Full Text] [Related]
4. Clonal Hematopoiesis and Premalignant Diseases.
Kaner J; Desai P; Mencia-Trinchant N; Guzman ML; Roboz GJ; Hassane DC
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31615870
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
6. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
7. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Clonal Hematopoiesis.
Steensma DP
Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
[TBL] [Abstract][Full Text] [Related]
9. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
Carr RM; Patnaik MM
Curr Opin Hematol; 2020 Jan; 27(1):2-10. PubMed ID: 31688455
[TBL] [Abstract][Full Text] [Related]
12. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
14. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
Jaiswal S; Libby P
Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
17. Obesity-induced inflammation exacerbates clonal hematopoiesis.
Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
[TBL] [Abstract][Full Text] [Related]
18. New Insights from Studies of Clonal Hematopoiesis.
Gibson CJ; Steensma DP
Clin Cancer Res; 2018 Oct; 24(19):4633-4642. PubMed ID: 29703819
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
[TBL] [Abstract][Full Text] [Related]
20. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
Fuster JJ; Walsh K
Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]